Leading medical experts on Monday urged the public to use antibiotics strictly under medical supervision, warning that careless consumption is accelerating the global threat of antibiotic resistance. Their remarks came after Prime Minister Narendra Modi cited findings from an Indian Council of Medical Research (ICMR) study highlighting the growing danger of antimicrobial resistance. Echoing the…
Sanofi went into the Christmas break with news of a takeover deal to boost its vaccines business, even as the FDA sent an early complete response letter for its oral multiple sclerosis candidate tolebrutinib. The timing of the decision came as a surprise, as the FDA delivered its verdict on Sanofi’s application months earlier than…
Losing weight may be a common new year resolution but health experts have warned against buying medications for such purposes from social media sellers or other illegitimate channels. Jabs such as Wegovy and Mounjaro have become hugely popular for weight loss, with trials suggesting the latter can help people lose an average of 20% of…
FDA wants to capitalize on the talent of venture capital (VC) firms that are developing innovative solutions that can be applied to FDA’s public health mission. On December 17, 2025, FDA issued a Request for Information (RFI) for its FIRE program, which stands for “Foundational Innovation and RAPID Engagement.” The proposal is intended to solicit…
Shots: Adlai Nortye has granted ASK Pharm exclusive rights to develop, manufacture, & commercialize AN9025 in mainland China, Hong Kong & Macao, with Adlai retaining rights in other regions As per the deal, Adlai will receive ~$230M, incl. >$20M in upfront & near-term milestone, plus tiered royalties ranging from a high single-digit to mid-teens %…
NICE has cleared the way for bevacizumab to be used by the NHS to treat colorectal cancer for the first time, thanks to the availability of lower-cost biosimilar versions of the drug. In recently published draft guidance (PDF), the reimbursement authority recommends the use of the anti-CD20 antibody alongside chemotherapy for people with previously untreated…
According to Tina Martinez, vice president and head of global products and solutions at Cencora, the wholesaler occupies a distinctive position within the global healthcare ecosystem, operating at the center of the pharmaceutical supply chain with a scale that extends well beyond the United States. As a global organization, the company is able to leverage…
Shots: The Chinese NMPA has accepted NDA & granted priority review to fanregratinib (HMPL-453) for the treatment of adults with advanced, metastatic, or unresectable ICC with FGFR 2 fusion/rearrangement who have previously received systemic therapy NDA was supported by the P-II trial in China, which met its 1EP of improved ORR, with 2EPs findings, incl….
Medicare and Medicaid are cornerstones of America’s healthcare system. Together, they provide care for more than 140 million people—from older adults to low-income families and people with disabilities. They represent among the largest federal expenditures, with Medicare spending approaching $900 billion annually and Medicaid spending nearly $734 billion in recent years. Yet the very size and complexity…
Expansion increases tablet and capsule production capacity from December 22, 2025 Share Corona Remedies has announced the commencement of capacity expansion for the commercial production of tablets and capsules at its Bhayla manufacturing facility, effective December 22, 2025. The expansion is intended to address market demand and increase in-house production capacity….